Daily Pivots: (S1) 1.0889; (P) 1.1035; (R1) 1.1116; More… Intraday bias in GBP/USD remains mildly on the downside with 1.1178 minor resistance intact. Deeper fall would be seen to retest 1.0351 low. On the upside, Read more…
Daily Pivots: (S1) 0.9916; (P) 0.9969; (R1) 1.0021; More… Intraday bias in USD/CHF stays neutral for the moment. While deeper retreat cannot be ruled out, break of 0.9779 support is needed to indicate short term Read more…
Whether you want a Pro, Mini, Air, or entry-level iPad, Amazon is discounting all of their tablets for the Prime Early Access Sale. With four models and five screen sizes to pick from, Apple’s iPad Read more…
The Nacho Fries are constantly being taken on and off the menu. While fan reaction (and outrage) over the Mexican Pizza remains unmatched in all of Taco Bell’s history, a close second are the Yum! Read more…
Daily Pivots: (S1) 145.56; (P) 145.73; (R1) 146.03; More… USD/JPY’s rally continues today and accelerates to as high as 146.81 so far. Intraday bias remains on the upside for 147.68 long term resistance. On the Read more…
Dollar surges further in early US session against Yen, after BoJ Governor Haruhiko Kuroda dropped no hint on intervention despite today’s Yen selloff. Indeed, he noted that Yen depreciation could be could for the economy Read more…
Watch the latest news on this morning’s producer price inflation data as earnings and the FOMC minutes loom. Watch TheStreet’s Market Open: Stock Market Today: Stocks Higher As October Rally Faces Inflation, Earnings TestMortgage Rates Read more…
BoJ Governor Haruhiko Kuroda said, “yen depreciation may have a good impact on macro-economy as a whole, but there are some sectors which are suffering from weak yen.” He added that “we have to carefully Read more…
BoE Chief Economist Huw Pill said in a speech, “Given the uncertain world and volatile markets we face, November can seem a long time away. At present, I am still inclined to believe that a Read more…
“Together we have made significant progress in advancing mRNA-4157 as an investigational personalized cancer treatment used in combination with (Merck & Co.’s) Keytruda,” Moderna said Wednesday. Moderna (MRNA) – Get Moderna Inc. Report shares surged higher Read more…